Table II.
Patient characteristics during interval between previously reported analysis (Leschek et al11) and AH measurement of patients in current analysis
| CAs* (y) | Patient No. | Height Velocity (cm/y) | BA (y) | Testicular Volume (mL) | Peak LH† (IU/L) | Peak FSH† (IU/L) | Testosterone (ng/dL) |
|---|---|---|---|---|---|---|---|
| 6 | 6 | 6.4 ± 2.0 | 11.0 ± 2.0 | 6.5 ± 1.4 | 4.8 ± 3.3 | 2.8 ± 2.5 | 209 ± 100 |
| 7 | 9 | 6.3 ± 1.8 | 11.4 ± 1.3 | 7.1 ± 1.2 | 6.6 ± 4.3 | 3.5 ± 2.7 | 195 ± 138 |
| 8 | 8 | 6.6 ± 1.4 | 11.7 ± 0.9 | 7.9 ± 0.9 | 7.2 ± 10.2 | 1.8 ± 1.7 | 204 ± 113 |
| 9 | 9 | 5.4 ± 1.3 | 12.0 ± 1.1 | 8.3 ± 1.4 | 1.7 ± 2.1 | 1.4 ± 1.8 | 210 ± 141 |
| 10 | 10 | 5.6 ± 1.8 | 12.7 ± 0.9 | 8.5 ± 1.6 | 2.1 ± 1.0 | 1.9 ± 1.3 | 214 ± 170 |
| 11 | 12 | 4.6 ± 1.3 | 13.2 ± 0.6 | 8.5 ± 2.3 | 2.7 ± 2.0 | 2.1 ± 1.9 | 235 ± 167 |
| 12 | 12 | 4.7 ± 2.3 | 13.8 ± 0.6 | 10.7 ± 5.7 | 3.0 ± 3.3 | 1.8 ± 1.8 | 232 ± 221 |
| 13 | 14 | 6.3 ± 6.0 | 15.3 ± 1.2 | 14.9 ± 5.2 | No data | No data | 414 ± 162 |
| 14 | 17 | 3.7 ± 2.8 | 16.6 ± 0.9 | 16.7 ± 4.6 | 18.5 ± 7.0 | 11.7 ± 7.3 | 443 ± 186 |
| 15 | 16 | 2.1 ± 1.7 | 17.3 ± 0.9 | 17.0 ± 4.3 | 25.3 ± 17.5 | 11.2 ± 7.4 | 507 ± 217 |
| 16 | 13 | 0.8 ± 0.6 | 18.2 ± 0.6 | 17.2 ± 2.9 | 24.9 ± 22.0 | 12.3 ± 11.1 | 499 ± 234 |
| 17 | 5 | 0.6 ± 0.7 | 18.8 ± 0.3 | 16.5 ± 5.2 | No data | No data | 432 ± 238 |
CA, Chronologic age.
Data are mean ± SD of all study measurements during interval between previously reported and current analysis.
*
Chronological age (y) of patient at previously reported analysis (Leschek et al11).
†
GnRH stimulation testing was not performed when GnRHa was unavailable owing to discontinuation by the manufacturer.